Pharmafile Logo
Pharmafocus logo
Advanced Search

Programme exposes counterfeit dangers

January 12, 2006
Manufacturing and Production

An undercover investigation by a TV documentary team has uncovered serious flaws in the policing of UK pharmaceutical wholesaling and …

News

AstraZeneca buys UK cancer research firm

January 4, 2006
Research and Development

AstraZeneca has bought a small UK biotech company KuDOS which specialises in cutting edge cancer research.AstraZeneca made its name in …

News

Woman wins right to Herceptin trial

December 22, 2005

A woman with breast cancer has been granted the right to take her PCT to court for barring access to …

News

Politics and Healthcare – still a volatile mix

December 22, 2005

Politics and the provision of healthcare are, it is generally agreed, ultimately inseparable; but their frequent interactions are a continual …

News

Bird flu tops 2005 global health concerns

December 22, 2005
Sales and Marketing

A survey conducted by the World Health Organisation has confirmed concerns over a possible bird flu pandemic as the year's …

News

Tamiflu-resistant bird flu found

December 22, 2005
Sales and Marketing

A report of two cases of bird flu which proved resistant to treatment with Tamiflu have been reported in the …

News

FDA approves Bayer’s kidney cancer drug

December 22, 2005
Sales and Marketing

Bayer's Nexavar has become the first treatment in more than ten years to receive approval in the US for the …

News

Pfizer lifted by Lipitor patent victory

December 20, 2005
Sales and Marketing

Shares in Pfizer have risen after it saw off a patent challenge to Lipitor, its biggest selling drug.Lipitor generates around …

News

An Inspector Calls

December 20, 2005

I have become a pharmacovigilance bore within my company – a prophet of doom. It is worse than that, because …

Feature

Right-sizing the salesforce

December 20, 2005
Sales and Marketing salesforce

 Can we form an impression about how good or ‘right’ a team is simply by the size of it? We …

Feature

Private sector vital for Government plans for patient choice

December 15, 2005
NHS, private sector

Patients are to be given more choice in their care as the NHS undertakes an ambitious set of reforms intended …

News

Prexige wins approval in UK

December 15, 2005
Sales and Marketing

Prexige has finally been launched in the UK after a safety review of the entire Cox-II class delayed its entrance …

News

Merck disappointed after jury undecided in Vioxx case

December 13, 2005
Sales and Marketing

Merck said it was disappointed after a jury failed to reach a unanimous decision in the first federal court case …

News

AstraZeneca doubles trial size for stroke drug

December 13, 2005
Research and Development AstraZeneca, stroke

 Late stage clinical trials of AstraZeneca’s new stroke treatment have resumed after the company decided to double the number of …

News

US regulator looks to improve communication strategy

December 13, 2005
Sales and Marketing

The FDA is investigating ways of improving its communication of the risks, including dangerous side-effects, linked with prescription drugs.The US …

News

Seven Stones wins General Electric Healthcare account

December 13, 2005
Medical Communications

Specialist healthcare communications agency Seven Stones has secured a new global account with General Electric Healthcare Discovery Systems.A subsidiary of …

News

Shire and New River expect new ADHD launch in 2006

December 8, 2005
Sales and Marketing

New River Pharmaceuticals has filed a new treatment for attention deficit hyperactivity disorder (ADHD) with US regulator the FDA.New River …

News

350 million needed for stem cell research

December 8, 2005
Research and Development

At least £350 million extra funding is needed for UK stem cell research if it is to maintain its international …

News

J&J submits new schizophrenia drug

December 8, 2005
Sales and Marketing

Johnson & Johnson has submitted a new schizophrenia drug to the FDA, and hopes it will succeed one of its …

News

McKillop calls for changes to EU pharmaceutical market

December 8, 2005
Research and Development

AstraZeneca's chief executive Sir Tom McKillop says action is needed on pricing and the clinical trials environment in order to …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026